Publications internationales

  C. Gomez, P. Ponien, N. Serradji, A. Lamouri, A. Pantel, E. Capton, V. Jarlier, G. Anquetin, A. Aubry. Synthesis of gatifloxacin derivatives and their biological activities against Mycobacterium leprae and Mycobacterium tuberculosis. Bioorganic & Medicinal Chemistry. 2013 ; 15 ;21(4) : 948-56.
  A. Bouige, A. Darmon, J. Piton, M. Roué, S. Petrella, E. Capton, P. Forterre, A. Aubry*, Mayer C*. The Mycobacterium tuberculosis DNA gyrase possesses two functional GyrA-boxes. Biochem J. 2013 ; 455(3) : 285-94 (*co-derniers auteures)
  A. Fillion, A. Aubry, F. Brossier, A. Chauffour, V. Jarlier, N. Veziris. Impact of Fluoroquinolone Resistance on Bactericidal and Sterilizing Activity of a Moxifloxacin-Containing Regimen in Murine Tuberculosis. Antimicrob Agents Chemother. 2013 ; 4496-500.
  A. Agrawal, M. Roué, C. Spitzfaden, S. Petrella, A. Aubry, MM. Hann, B. Bax, C. Mayer. Mycobacterium tuberculosis DNA gyrase ATPase domain structures suggest a dissociative mechanism that explains how ATP hydrolysis is coupled to domain motion. Biochem J. 2013 ; 456(2) : 263-73
  N. Veziris, A. Chauffour, S. Escolano, M. Matsuoka, V.Jarlier, A. Aubry. Resistance of Mycobacterium leprae to quinolones : a question of relativity ?" PLOS Neglected Tropical Diseases. 2013 ; 7(11) : e2559
  Mechaï F, Veziris N, Aoun O, Bille E, Lecuit M, Brossier F, Viard JP, Lortholary O. In vivo selection of a multidrug-resistant Mycobacterium avium isolate in a patient with AIDS. Int J Tuberc Lung Dis. 2013, 17(1):141-2.
  Fillion A, Aubry A, Brossier F, Chauffour A, Jarlier V, Veziris N. Impact of Fluoroquinolone Resistance on Bactericidal and Sterilizing Activity of a Moxifloxacin-Containing Regimen in Murine Tuberculosis. Antimicrob Agents Chemother 2013, 57(9):4496-500.
  Bernard C, Brossier F, Sougakoff W, Veziris N, Frechet-Jachym M, Metivier N, Renvoisé A, Robert J, Jarlier V, On Behalf Of The Mdr-Tb Management Group Of The Nrc C. A surge of MDR and XDR tuberculosis in France among patients born in the Former Soviet Union. Euro Surveill. 2013, 18(33):20555.
  Pang S*, Renvoisé* A, Perret C, Guinier M, Chelghoum N, Brossier F, Capton E, Jarlier V, Sougakoff W. Whole-genome sequence of Mycobacterium abscessus clinical strain V06705. Genome Announc. 2013, 1(5). (* equal contribution)
  C. Bernard, C. Wichlacz, M. Rigoreau, S. Sorhouet, R. Dagiral, V. Jarlier, N. Veziris. Evaluation of the Module Fluo-RAL(R) for fluorescent microscopy detection of tuberculous and non tuberculous acid-fast bacilli. J Clin Microbiol. 2013,51(10) : 3469-70
  Radomski N, Roguet A, Lucas FS, Veyrier FJ, Cambau E, Accrombessi H, Moilleron R, Behr MA, Moulin L. atpE gene as a new useful specific molecular target to quantify Mycobacterium in environmental samples. BMC Microbiol. 2013 Dec 3 ;13:277. doi : 10.1186/1471-2180-13-27
  J. Robert, D. Affolabi, F. Awokou, D. Nolna, B. Adou P. Manouan, Y.B. Acho, M. Gninafon, A. Trebucq. 2013. Assessment of organizational measures to prevent nosocomial tuberculosis in health facilities of 4 sub-Saharan countries in 2010. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 34 (2) p. 190-5
  T V Bui, V Meyssonnier, P Y Boelle, D Che, D Antoine, V Jarlier, J Robert. Decrease in the incidence of culture-positive meningitis and cerebral tuberculomas in France from 1990 to 2007. 2013. Epidemiology and infection p. 1-7
  Hilleman D, Hoffner S, Cirillo D. Drobniewski F., Richter E., Rusch-Gerdes S, The Baltic-Nordic TB-laboratory network, TB PAN-NET, ECDC ERLN-TB networks* (E. Cambau, V. Jarlier). First evaluation after implementation of a quality control system for the second line drug susceptibility testing of Mycobacterium tuberculosis joint efforts in low and high incidence countries. PLoS ONE 2013, 8(10):e76765.

  Publications nationales

  A. Renvoisé, F. Brossier, W. Sougakoff, V. Jarlier, A. Aubry. Broad-range PCR : Past, present, or future of bacteriology ? Med Mal Infect. 2013 ; 43(8):322-30
  N. Veziris. Les nouveaux antituberculeux (1) : nouvelles utilisations de molécules existantes. 2013. Volume 15, Issue 2, Pages 95-101
  N. Veziris. Les nouveaux antituberculeux (2) : nouvelles molécules Journal des Anti-infectieux, 2013. Volume 15, Issue 3, Pages 133-140

  Chapitres d’ouvrages

  P. Fraisse, N. Veziris. Chapitre Tuberculose in La pneumologie fondée sur des Preuves. Editions Margaud-Orange. 2013
  F. Mougari, L. Guglielmetti, A. Lopes, L. Raskine, E. Cambau. Mycobactérioses non tuberculeuses hors mycobactérioses cutanées. Revue Encyclopédie Médico Chirurgicale. 2013